Galvus Met Tablet is an anti-diabetic medicine that helps in lowering high blood sugar levels in patients suffering from Type 2 Diabetes. Being a combination medicine, it helps in preventing serious complications such as hepatic impairment, kidney problems, and blindness.
Galvus met contains the active ingredient Vildagliptin combined with Metformin, which is prepared in the form of vildagliptin/metformin hydrochloride ratios of 50mg/500mg, 50mg/850mg, 50mg/1000mg. The drug is indicated in the treatment of type 2 diabetes with the following specific uses:
Galvus met is indicated as an adjunct to diet and exercise to help improve blood sugar control in humans. type 2 diabetes mellitus with uncontrolled glycemic control with metformin hydrochloride, vildagliptin alone or in patients receiving combination therapy with metformin hydrochloride and vildagliptin tablets separately; Galvus met is indicated in combination with a sulfonylurea as an adjunct to diet and exercise in patients not adequately controlled by sulfonylurea and metformin; Galvus met is indicated in conjunction with insulin as an adjunct to diet and exercise to improve glycemic control in patients already receiving stable insulin and metformin for inadequate glycemic control.
